시장보고서
상품코드
1280735

신경독 시장 예측 - 제품 유형, 애플리케이션 및 최종 사용자별 분석

Neurotoxin Market Forecast to 2028 - Global Analysis By Product Type (Botox, Dysport, Xeomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)

발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 186 Pages | 배송안내 : 즉시배송


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경독 시장 규모는 2022년 66억 2,236만 3,600만 달러에서 2028년 131억 9,506만 달러에 달할 것으로 예상되며, 2023년부터 2028년까지 12.3%의 CAGR을 나타낼 것으로 추정됩니다.

전체 신경독 시장은 얼굴 미용에 대한 수요 증가로 인해 예측 기간 동안 기하급수적으로 성장할 것으로 예상되며, 2022년 3월, Aquavit Pharmaceuticals, Inc. 보툴리눔 톡신 'DTX-021'의 임상시험계획(IND) 제출을 발표했습니다. 이 제품은 보툴리눔균이 생산하는 신경독에서 유래한 900kDa의 단백질 복합체로, 고순도 및 임상시험이 완료된 주사제형 신경조절물질입니다. 또한, 아쿠아비트는 DTX-022의 도입으로 임상시험에 박차를 가하고 있으며, 최종 승인 시 세계 최초의 범안면 신경독 미세주사제로 인정받게 됩니다.

마찬가지로, 체중 감량 트렌드가 지속되면서 비침습적 시술을 원하는 환자들 사이에서 위 보톡스가 인기 있는 선택이 되고 있습니다. 보톡스는 내시경 기술을 사용하여 특정 위 부위에 보톡스를 주입합니다. 이 기술은 위 근육의 수축을 제한합니다. 위 배출 과정에 시간이 걸리기 때문에 포만감을 더 오래 느낄 수 있고, 식욕이 감소하여 고혈압, 당뇨병과 같은 체중과 관련된 건강 문제 및 생활습관병을 개선할 수 있습니다.

2021년 6월, 갈더마는 유럽 최초의 즉시 사용 가능한 신경 조절제 및 주름 개선 주사제인 신제품 'Alluzience'의 출시를 발표했습니다. 이번에 출시하는 'Alluzience'는 특히 성인 환자를 대상으로 한 A형 보툴리눔 톡신 액상 제제로, 중등도에서 중증의 눈썹 사이 세로주름을 일시적으로 개선하기 위한 제품입니다.

제품 유형에 따라 신경독 시장은 보톡스, 디스포트, 제모인, 기타로 분류됩니다. 보톡스 부문은 2022년 가장 큰 시장 점유율을 차지하고 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 보툴리눔 톡신은 의료 및 미용 산업에서 많은 인기를 얻고 있습니다. 가장 널리 사용되는 보툴리눔 톡신은 보툴리눔 A형입니다. 보툴리눔 톡신 시장은 주로 미적 감각 증가와 비침습적 미용 시술 증가에 의해 주도되고 있습니다. 또한, 치료의 질적 향상, 전문적 서비스 개선, 고도로 숙련된 미용외과 전문의의 최소침습적 수술 이용이 시술량 증가, 기술 발전, 비용 효율적인 미용 제품의 도입에 기여하고 있습니다. TGA)로부터 '레티보(Letybo)'의 승인을 받았다고 발표했습니다. 레티보는 그라벨라 라인의 적응증을 치료하기 위해 처방된 A형 보툴리눔 톡신 주사제다. 회사는 2023년 1분기 중 첫 출하를 완료하고 현지 시장에 출시할 예정입니다.

브랜드 선호도는 국가마다 다르며, 예를 들어 싱가포르에서 주로 사용되는 보툴리눔 톡신 브랜드는 Botox(Allergan), Dysport(Ipsen Biopharmaceuticals Inc.), Xeomin(Merz Pharmaceuticals, LLC)입니다. 이들은 Health Saving Account(HAS)의 승인을 받았습니다. 이들 브랜드의 가격은 보톡스 20.6-34.4달러(15-25싱가포르달러), 디스포트 16.5-27.5달러(12-20싱가포르달러), 제오민 20.6-27.5달러(15-20싱가포르달러)입니다. 에볼라스의 추정에 따르면 보톡스는 전체 보툴리눔 톡신 시장의 약 70%를 차지하는 가장 큰 시장 점유율을 가지고 있습니다. 마찬가지로 태국에서는 보톡스 알레르간(Botox Allergan)과 보톡스 에톡스(Botox Aestox)의 두 가지 주요 브랜드가 널리 사용되고 있으며, 태국 FDA의 승인을 받았습니다. 보톡스 알러간은 개당 2,802.8달러(79.98바트), 보톡스 에스톡스는 7,008달러(199.98바트)의 가격을 가지고 있습니다. 앞서 언급한 요인들은 2023년부터 2028년까지 신경독 시장의 부문별 성장 요인으로 작용하고 있습니다.

세계보건기구(WHO), 질병통제예방센터(CDC), 영국보건교육원(HEE), 국립보건원(NICE), 치료용품관리국(TGA), 영국보건복지부(NICE)(TGA)는 신경독 시장에 대한 보고서를 작성할 때 참고한 주요 1차 및 2차 정보입니다.

목차

제1장 서론

제2장 신경독 시장 - 중요 포인트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 신경독 시장 - 시장 구도

  • PEST 분석
    • 북미의 PEST 분석
    • 유럽 PEST 분석
    • 아시아태평양 PEST 분석
    • 중동 및 아프리카 PEST 분석
    • 중남미 PEST 분석
  • 전문가의 견해

제5장 신경독 시장 - 주요 시장 역학

  • 시장 성장 촉진요인
    • 외관을 개선하기 위한 미용 시술 급증
    • 혁신적인 안면 미용 제품의 등장
  • 시장 성장 억제요인
    • 부적절/부적당한 주사 기술
  • 시장 기회
    • 상지 근육의 경련을 줄이기위한 신경 독소
  • 향후 동향
    • 보조생식기술(ART)을 위한 BOTA
  • 영향 분석

제6장 신경독 시장 - 세계 분석

  • 세계의 신경독 시장 매출과 예측·분석
  • 세계의 신경독 시장, 지역별 예측·분석
  • 주요 기업의 시장 포지셔닝
  • 미용 주사 시술 건수와 미용성형외과 현역 의사수
  • 일본, 한국, 영국의 안면 수술 성별 내역
  • 미국의 비외과적 시술 : 성별
  • 미국의 비외과적 수술 : 연령층별
  • 미국의 외과적 시술 : 성별
  • 미국의 외과적 시술 : 연령층별
  • 영국의 외과적 시술 : 성별
  • 독일의 외과적 및 비외과적 시술 : 성별

제7장 세계의 신경독 시장 - 2028년까지 매출과 예측 : 유형별

  • 신경독 시장 매출 점유율 : 유형별(2022년, 2028년)
  • Botox
  • Dysport
  • Xeomin
  • 기타

제8장 세계의 신경독 시장 - 매출과 예측(-2028년) : 용도별

  • 신경독 시장 판매량 점유율 : 용도별(2022년, 2028년)
  • 치료용
  • 에스테틱

제9장 세계의 신경독 시장 - 2028년까지 매출과 예측 : 최종사용자별

  • 신경독 시장 판매량 점유율 : 최종사용자별(2022년, 2028년)
  • 병원
  • 메디컬 스파 및 뷰티센터
  • 피부과 클리닉
  • 기타

제10장 신경독 시장 - 2028년까지 매출과 예측 : 지역 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 폴란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 호주
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 중남미
    • 브라질
    • 아르헨티나
    • 베네수엘라
    • 기타 중남미
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 레바논
    • 기타 중동 및 아프리카

제11장 COVID-19 팬데믹이 신경독 시장에 미치는 영향

  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 중동 및 아프리카

제12장 신경독 시장 - 업계 상황

  • 신경독 시장의 성장 전략
  • 유기적인 성장 전략
  • 무기적 성장 전략

제13장 기업 개요

  • Merz Pharma GmbH & Co KGaA
  • AbbVie Inc
  • Revance Therapeutics Inc
  • Ipsen SA
  • Medytox Inc
  • Evolus Inc
  • Hugel Inc
  • Lanzhou Institute of Biological Products Co Ltd
  • Gufic
  • Metabiologics

제14장 부록

LSH 23.06.15

The neurotoxin market size is expected to reach US$ 13,195.06 million by 2028 from US$ 6,622.36 million in 2022; it is estimated to record a CAGR of 12.3% from 2023 to 2028.

The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins.

Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus.

In June 2021, Galderma announced a new product launch-"Alluzience"-intended to be the first ready-to-use neuromodulator and a wrinkle-relaxing injection in Europe. The newly launched product Alluzience is a liquid form of botulinum toxin type A, particularly for adult patients, to temporarily improve the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows).

Based on product type, the neurotoxin market is segmented into botox, dysport, xemoin, and others. The botox segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.. Botulinum toxins are much popular in the medical aesthetic industry. The widely used botulinum toxin is Botulinum type A. The botulinum toxin market is primarily driven by rising aesthetic consciousness and a number of noninvasive cosmetic procedures. In addition, the increasing quality of care, improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to procedural volume growth, technological advancements, and the introduction of cost-effective aesthetic products. In November 2022, Hugel, a medical aesthetic company in South Korea, announced receiving approval from Australia's Therapeutic Goods Administration (TGA) for its Letybo. Letybo is a botulinum toxin type A injection formulated to treat glabellar lines indications. The company plans to complete its first shipment and launch in the local market within the first quarter of 2023.

The preference of the brands differs in different countries; for instance, botulinum toxin brands that are largely used in Singapore are Botox (Allergan), Dysport (Ipsen Biopharmaceuticals Inc.), Xeomin (Merz Pharmaceuticals, LLC). These are Health Saving Account (HAS) approved. The prices of these brands are Botox US$ 20.6-34.4 (Singapore$ 15-25), Dysport US$ 16.5-27.5 (Singapore$ 12-20), and Xeomin US$ 20.6-27.5 (Singapore$ 15-20) per unit. As per Evolus's estimates, Botox has the maximum market share that holds ~70% of the total botulinum toxin's market. Similarly, in Thailand, two main brands, Botox Allergan and Botox Aestox, are widely used and approved by the Thai FDA. Botox Allergan costs US$ 2,802.8 (79.98 baht) and Botox Aestox costs US$ 7,008 (199.98 baht) per unit. These aforementioned factors are responsible for the segmental growth of the neurotoxin market during 2023-2028.

The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurotoxin market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global neurotoxin market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global neurotoxin market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Neurotoxin Market - by Type
    • 1.3.2 Global Neurotoxin Market - by Application
    • 1.3.3 Global Neurotoxin Market - by End User
    • 1.3.4 Global Neurotoxin Market - by Geography

2. Neurotoxin Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Neurotoxin Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Neurotoxin Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
    • 5.1.2 Emergence of Innovative Facial Aesthetic Products
  • 5.2 Market Restraints
    • 5.2.1 Improper/Inappropriate Injection Technique
  • 5.3 Market Opportunities
    • 5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
  • 5.4 Future Trends
    • 5.4.1 BOTA for Assisted Reproductive Technology (ART)
  • 5.5 Impact Analysis

6. Neurotoxin Market - Global Analysis

  • 6.1 Global Neurotoxin Market Revenue Forecast and Analysis
  • 6.2 Global Neurotoxin Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players
  • 6.4 Number of Cosmetic Injectable Procedures and Active Physicians at Cosmetic Surgery Departments
  • 6.5 Facial Procedures in Japan, South Korea, and the UK by Gender Identity
  • 6.6 Non-surgical Procedures in the US, by Gender Identity
  • 6.7 Non-surgical Procedures in the US, by Age Group
  • 6.8 Surgical Procedures in the US, by Gender Identity
  • 6.9 Surgical Procedures in the US, by Age Group
  • 6.10 Surgical Procedures in the UK, by Gender Identity
  • 6.11 Surgical and Non-surgical Procedures in Germany, by Gender Identity

7. Global Neurotoxin Market - Revenue and Forecast to 2028 - By Type

  • 7.1 Overview
  • 7.2 Neurotoxin Market Revenue Share, by Type (2022 and 2028)
  • 7.3 Botox
    • 7.3.1 Overview
    • 7.3.2 Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Dysport
    • 7.4.1 Overview
    • 7.4.2 Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Xeomin
    • 7.5.1 Overview
    • 7.5.2 Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Neurotoxin Market - Revenue and Forecast to 2028 - By Application

  • 8.1 Overview
  • 8.2 Neurotoxin Market Revenue Share, by Application (2022 and 2028)
  • 8.3 Therapeutic
    • 8.3.1 Overview
    • 8.3.2 Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Aesthetic
    • 8.4.1 Overview
    • 8.4.2 Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Neurotoxin Market - Revenue and Forecast to 2028 - By End User

  • 9.1 Overview
  • 9.2 Neurotoxin Market Revenue Share, by End User (2022and 2028)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Medical Spas and Beauty Centers
    • 9.4.1 Overview
    • 9.4.2 Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Dermatology Clinics
    • 9.5.1 Overview
    • 9.5.2 Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

10. Neurotoxin Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Neurotoxin Market
    • 10.1.1 Overview
    • 10.1.2 North America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    • 10.1.4 North America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    • 10.1.5 North America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
    • 10.1.6 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
      • 10.1.6.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  • 10.2 Europe: Neurotoxin Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    • 10.2.4 Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    • 10.2.5 Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
    • 10.2.6 Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 UK: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.1.4 UK: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.1.5 UK: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 Germany: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.2.4 Germany: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.2.5 Germany: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.3 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.3.4 France: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.3.5 France: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.4 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.5 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.6 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Poland: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.6.4 Poland: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.6.5 Poland: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.7 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.7.1 Overview
        • 10.2.6.7.2 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.7.3 Russia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.7.4 Russia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.7.5 Russia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.8 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.8.1 Overview
        • 10.2.6.8.2 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.8.3 Rest of Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.2.6.8.4 Rest of Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.2.6.8.5 Rest of Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  • 10.3 Asia Pacific: Neurotoxin Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 Australia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.3.6.1.4 Australia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.1.5 Australia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 China: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.3.6.2.4 China: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.2.5 China: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.3 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.3.6.3.4 India: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.3.5 India: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.4 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 Japan: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.3.6.4.4 Japan: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.4.5 Japan: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.5 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 South Korea: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.3.6.5.4 South Korea: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.5.5 South Korea: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  • 10.4 South and Central America: Neurotoxin Market
    • 10.4.1 Overview
    • 10.4.2 South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    • 10.4.4 South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    • 10.4.5 South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
    • 10.4.6 South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
      • 10.4.6.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 Brazil: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.4.6.1.4 Brazil: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.4.6.1.5 Brazil: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.4.6.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 Argentina: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.4.6.2.4 Argentina: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.4.6.2.5 Argentina: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.4.6.3 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 Venezuela: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.4.6.3.4 Venezuela: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.4.6.3.5 Venezuela: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.4.6.4 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.4.6.4.4 Rest of South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.4.6.4.5 Rest of South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  • 10.5 Middle East and Africa: Neurotoxin Market
    • 10.5.1 Overview
    • 10.5.2 Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    • 10.5.4 Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    • 10.5.5 Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
    • 10.5.6 Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 South Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.5.6.1.4 South Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.5.6.1.5 South Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Saudi Arabia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.5.6.2.4 Saudi Arabia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.5.6.2.5 Saudi Arabia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.3 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 UAE: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.5.6.3.4 UAE: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.5.6.3.5 UAE: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.4 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.1 Overview
        • 10.5.6.4.2 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.3 Israel: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.5.6.4.4 Israel: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.5.6.4.5 Israel: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.5 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.5.1 Overview
        • 10.5.6.5.2 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.5.3 Lebanon: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.5.6.5.4 Lebanon: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.5.6.5.5 Lebanon: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.6 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.6.1 Overview
        • 10.5.6.6.2 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.6.3 Rest of Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
        • 10.5.6.6.4 Rest of Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
        • 10.5.6.6.5 Rest of Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Neurotoxin Market

  • 11.1 North America: Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Neurotoxins Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Neurotoxins Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Merz Pharma GmbH & Co KGaA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 AbbVie Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Revance Therapeutics Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Ipsen SA
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Medytox Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Evolus Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 1SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Hugel Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Lanzhou Institute of Biological Products Co Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Gufic
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Metabiologics
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제